Aktienanalyse zu American Vanguard Corporation (AVD)AVDAmerican Vanguard Corporation

American Vanguard Corporation is a diversified specialty and agriculture products company, which develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. It conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. It synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection. These products, which include insecticides, fungicides, and biorationals, are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It operates in the Basic Materials sector (AGRICULTURAL CHEMICALS industry).

American Vanguard Corp is not a good buy right now due to its declining performance and negative financial indicators. The current price is $2.19, which is significantly down 42.52% year-to-date and 59.44% over the past year. The RSI is at 43.50, indicating a neutral momentum, and the forward P/E ratio is 15.08, suggesting potential overvaluation given the current financial struggles. The main risk is the high debt to equity ratio of 147.54%, which indicates a heavy reliance on debt financing, posing a risk to stability.

4 analysts cover AVD: 3 rate it Buy, 1 Hold and 0 Sell.